BREAST CYTOPATHOLOGY

174 Index
Papilloma (cont.)
invasive ductal carcinoma
not otherwise specified
(NOS), 96
invasive micropapillary
carcinoma, 106
proliferative breast disease,
25
infarcted, 72
intraductal, 67–73
clinical features of, 67–68
cytomorphologic
characteristics of, 68–72
differential diagnoses of,
63, 72–73
as “gray zone diagnosis,”
27
multiple, 67, 68
Papillomatosis, 22, 67, 70
differential diagnoses of
carcinoma with
osteoclastic-type giant
cells, 128
ductal carcinoma in situ, 91
invasive ductal carcinoma
not otherwise specified
(NOS), 96
invasive micropapillary
carcinoma, 106
myofibroblastoma, 79
secretory carcinoma, 116
“Peau d’orange” skin changes,
91
“Phyllodes fragments,” 63, 64
Phyllodes tumors, 63–67
benign, 63, 64, 65, 66
clinical features of, 63
cytomorphologic
characteristics of, 63–66
differential diagnoses of, 67
fibroadenoma, 63, 67
metaplastic carcinoma, 127
pseudoangiomatous
stromal hyperplasia, 54
malignant, 63, 66, 67,
133–134
Plasma cell tumors, 139
Plasmacytoma, 139, 141, 142
Pneumothorax, fine-needle
aspiration-related, 5
Pregnancy-related breast
changes, 43–46
differential diagnoses of
inflammatory breast
conditions, 120
lobular carcinoma in situ,
98
Primary malignant tumors,
85–137
Proliferative breast disease,
22–28
with atypia, 22
clinical features of, 22
cytomorphologic
characteristics of, 22–25
fine-needle aspiration
reporting in, 26–28
Prostate cancer, metastatic, 143
Pseudoangiomatous stromal
hyperplasia, 53–54
differential diagnoses of, 46
myofibroblastoma, 79
reactive spindle cell
nodules, 55
R
Radiation-related breast
changes, 38–39
differentiated from
angiosarcoma, 133
Reactive spindle cell nodules,
55
Renal cancer, metastatic, 121,
143